Journal article
Comparative risk of new-onset diabetes following commencement of antipsychotics in New Zealand: a population-based clustered multiple baseline time series design
Abstract
OBJECTIVE: Newer antipsychotics are increasingly prescribed off-label for non-psychotic ailments both in primary and secondary care settings, despite the purported risk of weight gain and development of type 2 diabetes mellitus. This study aims to determine any relationship between the development of clinically significant new-onset type 2 diabetes mellitus and novel antipsychotic use in New Zealand using hypnotic drugs as control.
DESIGN: A …
Authors
Currie O; Williman J; Mangin D; McKinnon-Gee B; Bridgford P
Journal
BMJ Open, Vol. 9, No. 2,
Publisher
BMJ
Publication Date
February 2019
DOI
10.1136/bmjopen-2018-022984
ISSN
2044-6055